Literature DB >> 2175705

Cytomegalovirus-specific B cell activation as a potential marker for the diagnosis of cytomegalovirus infection.

M Segondy1, J P Vendrell, J Reynes, M F Huguet, B Albat, J Ducos, J C Nicolas, A Serre.   

Abstract

In vitro secretion of antibodies to cytomegalovirus was investigated by analysis of peripheral blood mononuclear cell culture supernatants from subjects infected with cytomegalovirus. Patients with primary or recurrent cytomegalovirus infection showed transient in vitro cytomegalovirus-specific antibody secretion. A high proportion of patients infected with human immunodeficiency virus and sero-positive for cytomegalovirus showed in vitro cytomegalovirus-specific antibody secretion. All peripheral blood mononuclear cell cultures from patients with symptomatic human immunodeficiency virus infection were found to secrete in vitro antibodies to cytomegalovirus, despite the fact that isolation of cytomegalovirus from some of these patients was not achieved. In human immunodeficiency virus-infected patients, in vitro secretion of anti-cytomegalovirus antibodies appeared to be persistent. In vitro cytomegalovirus-specific antibody secretion by peripheral blood lymphocytes probably reflects an in vitro cytomegalovirus-specific B cell activation. This new assay could be considered an interesting method for detecting both acute or chronic cytomegalovirus infection, with potential use in routine laboratory practice.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2175705     DOI: 10.1007/BF02184687

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  31 in total

1.  Immune response to acute diarrhea seen as circulating antibody-secreting cells.

Authors:  A M Kantele; R Takanen; H Arvilommi
Journal:  J Infect Dis       Date:  1988-11       Impact factor: 5.226

2.  Comparative sensitivity of three methods for the diagnosis of cytomegalovirus lung infection.

Authors:  P R Stirk; P D Griffiths
Journal:  J Virol Methods       Date:  1988-06       Impact factor: 2.014

3.  In-vitro secretion of HIV-specific antibodies by peripheral blood cells.

Authors:  J P Vendrell; J Reynes; H Rabesandratana; G Marguerite; P Corbeau; A Serre; M F Huguet; A Cannat
Journal:  Lancet       Date:  1988-07-30       Impact factor: 79.321

4.  Antigen-induced in vitro antibody production in humans: tetanus toxoid-specific antibody synthesis.

Authors:  D J Volkman; S P Allyn; A S Fauci
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

5.  Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. Centers for Disease Control, U.S. Department of Health and Human Services.

Authors: 
Journal:  Ann Intern Med       Date:  1986-08       Impact factor: 25.391

6.  Herpesvirus infections in the acquired immune deficiency syndrome.

Authors:  G V Quinnan; H Masur; A H Rook; G Armstrong; W R Frederick; J Epstein; J F Manischewitz; A M Macher; L Jackson; J Ames
Journal:  JAMA       Date:  1984-07-06       Impact factor: 56.272

7.  Activation of human B lymphocytes after immunization with pneumococcal polysaccharides.

Authors:  J H Kehrl; A S Fauci
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

Review 8.  Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment.

Authors:  M A Jacobson; J Mills
Journal:  Ann Intern Med       Date:  1988-04       Impact factor: 25.391

9.  Cytomegalovirus infections in homosexual men. An epidemiological study.

Authors:  L Mintz; W L Drew; R C Miner; E H Braff
Journal:  Ann Intern Med       Date:  1983-09       Impact factor: 25.391

10.  Rapid detection and quantitation of human cytomegalovirus in urine through DNA hybridization.

Authors:  S Chou; T C Merigan
Journal:  N Engl J Med       Date:  1983-04-21       Impact factor: 91.245

View more
  4 in total

1.  Secretion of Toxoplasma gondii-specific antibody in vitro by peripheral blood mononuclear cells as a new marker of acute toxoplasmosis.

Authors:  J P Vendrell; F Pratlong; A Decoster; P Boulot; A M Conge; F Darcy; M Segondy; M F Huguet; A Serre
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

2.  In vitro antibody secretion by peripheral blood mononuclear cells as an expression of the immune response to Brucella spp. in humans.

Authors:  J P Vendrell; A M Conge; M Segondy; S Lombroso; M F Huguet; A Bertrand; F Janbon; A Serre
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

3.  Hepatitis C virus (HCV)-specific in vitro antibody secretion by peripheral blood lymphocytes: correlation with progression of disease and HCV RNA in HCV antibody-positive patients.

Authors:  J Ducos; A M Bianchi-Mondain; M Francois; M Boisset; J P Vendrell; F Barin; A Serre; D Larrey
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

4.  Blood and alveolar lymphocyte subsets in pulmonary cytomegalovirus infection after lung transplantation.

Authors:  F Stéphan; J F Bernaudin; D Cesari; A Fajac; D Grenet D; I Caubarrere; M Stern
Journal:  BMC Infect Dis       Date:  2001-09-17       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.